When levels drop too low, familiar symptoms appear: nagging fatigue, stubborn brain fog, weakened immunity
GLP-1 receptor agonists, a class of drugs originally developed for type 2 diabetes and obesity that have recently transformed metabolic medicine, target the downstream consequences of that hormonal withdrawal: dysregulated energy metabolism, inflammation, and shifts in body composition
Our genetic test assesses variants in antioxidant and metabolic pathways that influence how your body processes glutathione and handles oxidative stress
Jain MS, Prasanthi S, Bommala ND, Goudanavar P, Naveen NR (2025) Harnessing the human microbiome for innovative drug delivery systems: exploring pharmacomicrobiomics and targeted therapies